Abstract
The central anticholinergic syndrome (CAS) is caused by pharmacologic substances that have anticholinergic actions. We report a case in which glycopyrrolate appears to have been responsible for a particularly severe episode of CAS
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
